Insulin and glucose play a role in foam cell formation and function

Cardiovascular Diabetology

Volumn 5, Issue , 2006, Pages

  Shashkin, Pavel N ^a,b   Jain, Nitin ^a,c   Miller, Yury I ^d   Rissing, Benjamin A ^a   Huo, Yuqing ^a,e   Keller, Susanna R ^a   Vandenhoff, George E ^a   Nadler, Jerry L ^a   McIntyre, Thomas M ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c PFIZER INC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; AMINOPEPTIDASE; EXTENSIVELY OXIDIZED LOW DENSITY LIPOPROTEIN; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; ICOSANOID; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPROTEIN; MINIMALLY MODIFIED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETES MELLITUS; DOWN REGULATION; ENZYME PHOSPHORYLATION; FOAM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; LIPID OXIDATION; MACROPHAGE; PROTEIN MICROARRAY; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; UPREGULATION;

CELL DIFFERENTIATION; CELLS, CULTURED; CHOLESTEROL; CYTOKINES; FOAM CELLS; GENE EXPRESSION; GLUCOSE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; INSULIN; LIPOPROTEINS, LDL; MACROPHAGES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 33747598913     PISSN: 14752840     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-5-13     Document Type: Article

References (62)

1. Lusis AJ: Atherosclerosis. Nature 2000, 407:233-241.
2. Streblow DN, Orloff SL, Nelson JA: Do pathogens accelerate atherosclerosis? J Nutr 2001, 131:2798S-2804S.
3. Candido R, Srivastava P, Cooper ME, Burrell LM: Diabetes mellitus: a cardiovascular disease. Curr Opin Investig Drugs 2003, 4:1088-1094.
4. Rett K: The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome. Diabetes Obes Metab 1999, 1(Suppl 1):S8-16.
5. de Villiers WJ, Smart EJ: Macrophage scavenger receptors and foam cell formation. J Leukoc Biol 1999, 66:740-746.
6. Osterud B, Bjorklid E: Role of monocytes in atherogenesis. Physiol Rev 2003, 83:1069-1112.
7. Iida KT, Suzuki H, Sone H, Shimano H, Toyoshima H, Yatoh S, Asano T, Okuda Y, Yamada N: Insulin inhibits apoptosis of macrophage cell line, THP-1 cells, via phosphatidylinositol-3-kinase-dependent pathway. Arterioscler Thromb Vasc Biol 2002, 22:380-386.
8. Daneman D, Zinman B, Elliott ME, Bilan PJ, Klip A: Insulin-stimulated glucose transport in circulating mononuclear cells from nondiabetic and IDDM subjects. Diabetes 1992, 41:227-234.
9. Liang CP, Han S, Okamoto H, Carnemolla R, Tabas I, Accili D, Tall AR: Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest 2004, 113:764-773.
10. Simeoni E, Hoffmann MM, Winkelmann BR, Ruiz J, Fleury S, Boehm BO, Marz W, Vassalli G: Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 2004, 47:1574-1580.
11. Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y: Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in a 2- way relationship. J Periodontol 2003, 74:97-102.
12. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
13. Miller YI, Viriyakosol S, Binder CJ, Feramisco JR, Kirkland TN, Witztum JL: Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD- 2, and inhibits phagocytosis of apoptotic cells. J Biol Chem 2003, 278:1561-1568.
14. Shashkin P, Dragulev B, Ley K: Macrophage differentiation to foam cells. Curr Pharm Design 2005, 11:3061-3072.
15. Kita T, Kume N, Minami M, Hayashida, K, Murayama T, Sano H, Moriwaki H, Kataoka H, Nishi E, Horiuchi H, Arai H, Yokode M: Role of oxidized LDL in atherosclerosis. Ann NY Acad Sci 2001, 947:199-205.
16. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998, 93:229-240.
17. Han J, Nicholson AC, Zhou X, Feng J, Gotto AM Jr. Hajjar DP: Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor 8-1. J Biol Chem 2001, 276:16567-16572.
18. Miller YI, Viriyakosol S. Worrall DS, Boullier A, Butler S, Witztum JL: Toll- Like Receptor 4-Dependent and Independent Cytokine Secretion Induced by Minimally Oxidized Low-Density Lipoprotein in Macrophages. Arterioscler Thromb Vasc Biol 2005, 25: 1-7.
19. Miller YI, Worrall DS, Funk CD, Feramisco JR, Witztum JL: Actin Polymerization in Macrophages in Response to Oxidized LDL and Apoptotic Cells: Role of 12/15-Lipoxygenase and Phosphoinositide 3-Kinase. Mol Biol Cell 2003, 14:4196-4206.
20. Bey EA, Cathcart MK: In vitro knockout of human p47phox blocks superoxide anion production and LDL oxidation by activated human monocytes. J Lipid Res 2000, 41:489-495.
21. Niskanen I, Rauramaa R, Miettinen H, Haffher SM, Mercuri M, Uusitupa M: Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects. Stroke 1996, 27:1986-1992.
22. Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P: Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992, 140:301-316.
23. Pitsilos S, Hunt J, Mohler ER, Prabhakar AM, Poncz M, Dawicki J, Khalapyan TZ, Wolfe ML, Fairman R, Mitchell M, Carpenter J, Golden MA, Cines DB, Sachais BS: Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost 2003, 90:1112-1120.
24. Boisvert WA: Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 2004, 14:161-165.
25. Gamble W, Vaughan M, Kruth HS, Avigan J: Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells. J Lipid Res 1978, 19:1068-1070.
26. Jain N, Thatte J, Braciale T, Ley K, O'Connell M, Lee JK: Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics 2003, 19:1945-1951.
27. Eisen MB, Spellman PT. Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95:14863-14868.
28. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, Golub TR: Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 1999, 96:2907-2912.
29. Steinberg D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997, 272:20963-20966.
30. Huang ZH, Gu D, Mazzone T: Oleic acid modulates the post-translational glycosylation of macrophage ApoE to increase its secretion. J Biol Chem 2004, 279:29195-29201.
31. Chantry D, Vojtek A, Kashishian A, Holtzman DA, Wood C, Gray PW, Cooper JA, Hoekstra MF: p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes. J Biol Chem 1997, 272:19236-19241.
32. Buchou T, Gaben AM, Phan-Dinh-Tuy F, Mester J: Insulin/insulin-like growth factor 1 induce actin transcription in mouse fibroblasts expressing constitutively myc gene. Mal Cell Endocrinol 1991, 75:181-187.
33. Taha C, Klip A: The insulin signaling pathway. J Membr Biol 1999, 169:1-12.
34. White MF: IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002, 283:E413-422.
35. Entingh-Pearsall A, Kahn CR: Differential roles of the insulin and insulin-like growth factor-1 (IGF-1) receptors in response to insulin and IGF-1. J Biol Chem 2004, 279:38016-38024.
36. Iritani N: Nutritional and insulin regulation of leptin gene expression. Curr Opin Clin Nutr Metab Care 2000, 3:275-279.
37. Yang T, Espenshade PJ, Wright ME, Yabe D, Gong Y, Aebersold R, Goldstein JL, Brown MS: Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 2002, 110:489-500.
38. Artie AD: Insig: a significant integrator of nutrient and hormonal signals. J Clin Invest 2004, 113:1112-1114.
39. McPherson R, Gauthier A: Molecular regulation of SREBP function: the Insig- SCAP connection and isoform-specific modulation of lipid synthesis. Biochem Cell Biol 2004, 82:201-211.
40. Yabe D, Komuro R, Liang G, Goldstein JL, Brown MS: Liver-specific mRNA for Insig-2 down-regulated by Insulin: implications for fatty acid synthesis. Proc Natl Acad Sci USA 2003, 100:3155-3160.
41. Keller SR: The insulin-regulated aminopeptidase: a companion and regulator of GLUT4. Front Biosci 2003, 8:s410-s420.
42. Keller SR: Role of the insulin-regulated aminopeptidase IRAP in insulin action and diabetes. Biol Pharm Bull 2004, 27:761-764.
43. Spanbroek R, Grabner R, Lotzer K, Hildner M, Urbach A, Ruhling K, Moos MP, Kaiser B, Cohnert TU, Wahlers T, Zieske A, Plenz G, Robenek H, Salbach P, Kuhn H, Radmark O, Samuelsson B, Habenicht AJ: Expanding expression of the 5- lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 2003, 100:1238-1243.
44. Radmark O: 5-lipoxygenase-derived leukotrienes: mediators also of atherosclerotic inflammation. Arterioscler Thromb Vase Biol 2003, 23:1140-1142.
45. Spanbroek R, Habenicht AJ: The potential role of antileukotriene drugs in atherosclerosis. Drug News Perspect 2003, 16:485-489.
46. Haffner SM: Insulin resistance, inflammation, and the prediabetic state. Am J Cordiol 2003, 92:18J-26J.
47. Spranger J, Kroke A, Mohlig M, Hoffmann K. Bergmann MM, Ristow M, Boeing H, Pfeiffer AF: Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003, 52:812-817.
48. Dandona P, Aljada A, Bandyopadhyay A: Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004, 25:4-7.
49. Saltiel AR, Pessin JE: Insulin signaling pathways in time and space. Trends Cell Biol 2002, 12:65-71.
50. Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Febbraio M, Saltin B: Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil 2003, 24:113-119.
51. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohisson C, Jansson JO: Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002, 8:75-79.
52. Di Gregorio GB, Hensley L, Lu T, Ranganathan G. Kern PA: Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab 2004, 287:E182-187.
53. Senn JJ, Klover PJ, Nowak IA, Mooney RA: Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 2002, 51:3391-3399.
54. Klover PJ, Clementi AH, Mooney RA: Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 2005, 146:3417-3427.
55. Mover PJ, Zimmers TA, Koniaris LG, Mooney RA: Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 2003, 52:2784-2789.
56. Juhan-Vague I, Alessi MC, Mavri A, Morange PE: Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk. J Thromb Haemost 2003, 1:1575-1579.
57. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano, M, Moriwaki H, Seishima M: Lack of interleukin-Ibeta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:656-660.
58. Phillips JW, Barringhaus KG, Sanders JM, Yang Z, Chen M, Hesselbacher S, Czarnik AC, Ley K, Nadler J, Sarembock IJ: Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes. Circulation 2003, 108:1994-1999.
59. Davenport P, Tipping PG: The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003, 163:1117-1125.
60. Montagnani M, Golovchenko I, Kim I, Koh GY, Goalstone ML, Mundhekar AN, Johansen M, Kucik DF, Quon MJ, Draznin B: Inhibition of phosphatidylinositol 3- kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 2002, 277:1794-1799.
61. Han J, Hajjar DP, Febbraio M, Nicholson AC: Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem 1997, 272:21654-21659.
62. Tsukamoto K, Kinoshita M, Kojima K, Mikuni Y, Kudo M, Mori M, Fujita. M, Horie E, Shimazu N, Teramoto T: Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages. J Atheroscler Thromb 2002, 9:57-64.